APOD and Obesity: In our study, receiver operating characteristic (ROC) analysis revealed that serum concentrations of Apo-A1, Apo-A2, Apo-C1, and Apo-D might act as specific and sensitive biomarkers for the prediction of the development of overweight and obesity in subjects after the cessation of anticancer therapy.